Donegan W L, Harris P
Cancer. 1976 Oct;38(4):1479-83. doi: 10.1002/1097-0142(197610)38:4<1479::aid-cncr2820380406>3.0.co;2-7.
Fifteen patients were treated with intra-arterial fluorouracil, methotrexate, and bleomycin in combination for palliation of advanced cancer of the head and neck. In all cases irradiation or irradiation plus surgical resection had previously failed to control the tumor. Tumor regression occured in 87% of the cases (13/15), and was complete in three (20%). Regressions lasted for up to 13 months. In four instances tumor regression permitted radical resection. The response rate achieved with this drug combination was greater than that observed earlier using each drug individually. Intra-arterial chemotherapy provides useful palliation for advanced head and neck cancer and the results can be improved with drug combinations.
15例晚期头颈癌患者接受了动脉内氟尿嘧啶、甲氨蝶呤和博来霉素联合治疗以缓解症状。所有病例此前经放疗或放疗加手术切除均未能控制肿瘤。87%的病例(13/15)出现肿瘤消退,其中3例(20%)完全消退。消退持续长达13个月。4例患者肿瘤消退后可行根治性切除。该联合用药方案的缓解率高于此前单独使用每种药物时观察到的缓解率。动脉内化疗可为晚期头颈癌提供有效的姑息治疗,联合用药可改善治疗效果。